Journal profile

Clinical neuropharmacology

Publisher: Lippincott Williams & Wilkins
ISSN0362-5664 | 1537-162X FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
2.78
Citation rate 1.60 124 total citations
h5-index 15 h5 depth signal
Cited share 72.5% 58 of 80
Total citations 124 Citation footprint
Metric signal 1.44 External metric anchor
Self-citation 1.6% 2 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 137
Turkey 82
China 72
Japan 40
Italy 30

Citing Fields of Research

Psychiatry 201
Brain Neurological Disorders 139
Neurodegenerative Disorders 107
Migraines & Headaches 60
Neurosciences 51

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 4,994 Articles tracked across the journal lifetime
Indexed publication set 80 58 cited publications
Last 12 months 45 4.1 publications/month
Open access share 8.9% 4 OA publications in the last year
Leading citing country United States 137 citing publications
Leading citing field Psychiatry 201 citing publications
Latest tracked publication 23 September 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v5n1, 1982-
PubMed
v5n1, 1982-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Psychiatry Brain Neurological Disorders Neurodegenerative Disorders Neurodevelopmental Disorders Neurosciences

Broad Categories

Psychopharmacology Psychiatry Migraines & Headaches Neuromuscular Disorders Brain Neurological Disorders Neurodegenerative Disorders Neurodevelopmental Disorders

MeSH Descriptors

Psychopharmacology

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Celia Garcia-Malo, Raquel Martín García, Sara Boi
Objectives: Dopamine agonists (DA) were the first-line therapy for restless legs syndrome (RLS) for many years, but their long-term use is limited by augmentation: a paradoxical worsening of symptoms. Managing augmentation remains a clin...
02
Jamir Pitton Rissardo, Jorge Luis Vargas Rojas, Juan Aristizabal Marin et al.
Objectives: OFF episodes are a major source of disability in Parkinson disease (PD). Noninjectable apomorphine formulations, including inhaled (INH) and sublingual (SL) delivery systems, provide rapid dopaminergic stimulation for on-dema...
05
Zachary Goodrich, Jennifer Schneider
Objective: Copper deficiency myelopathy is an uncommon but potentially reversible neurologic disorder characterized by sensory ataxia, gait impairment, and dorsal column dysfunction. Acquired copper deficiency most commonly results from ...
06
Stephen I. Deutsch, Jeffrey Elikan, David R. Spiegel et al.
Last of the Just, a novel of historical fiction published in 16 languages and recipient of France’s highest literary award, is recognized for its scholarly contribution to Holocaust education and conceptualization of the Lamid Vavnik, on...
10
Mehmet Murat Kırpınar, Büşra Uçar Bostan, Christopher Deniz Polat et al.
Objectives: Clozapine is regarded as the gold standard pharmacotherapy agent for treatment-resistant schizophrenia patients. However, myocarditis and pericarditis, which are significant life-threatening side effects of clozapine, should ...

Bibliographical & Catalog Notes

Imprint varies.

Editor: v. 1- H. L. Klawans.

Also issued online.

Vol. 9, no. 1 (FEB 1986)19900914 Notice not published Printed on acid-free paper